Organo-Consulting
Bridging Business & Science
in the Preclinical Industry
Services
With eight years of expertise in both science and business related to in vitro assays and MPS, I offer specialized services to help you navigate this complex and rapidly evolving market, strategically positioning your business to capitalize on emerging opportunities and generate value.
Product Development Strategy & Tech Assessment
Effective planning for product development to gain a competitive edge and maximize value
-
Advisory and guidance for new product & service development
-
Evaluation of scientific and business potential for R&D, M&A, and product prioritization
Strategic
Marketing
Enhance your business capabilities and efficiency by refining your market positioning:
-
Market and needs analysis, STP
-
Identification of market gaps, opportunities, and competitive landscape
-
Development of go-to-market strategies
Business Development
Boost your sales by targeting the right customer segments:
-
Sales and business development
-
Scouting and identifying new business opportunities
-
Creation of targeted marketing materials
Why choosing Organo-Consulting
Time & cost-saving
Consider both scientific, business, and strategic perspectives for comprehensive and accurate analysis.
Strong knowledge
Eight years experience in the MPS & in vitro industry
Personalized approach
Highlighting the uniqueness of your business to stand out from your competitors
Proven track record
-
Successful exit of the company Neurix
-
Led Finnadvance / AKITA to achieve sustainable sales growth
Dual business & scientific background
PhD and eMBA with 8 years of experience as COO and CSO, managing both R&D and business development jointly
Partners
About Organo-Consulting
Organo-Consulting is the business entity under which I – Sébastien Mosser – offer my freelance consulting services.
I hold a PhD in Neuroscience from EPFL (Switzerland) and a joint eMBA from Helbus (Finland) and Northampton (UK) universities, bringing a unique blend of scientific and business expertise. With 8 years of experience in MPS, I have served as both CSO and COO, managing R&D and business development simultaneously.
​
After completing my PhD, I joined the MPS startup Neurix, which successfully exited. I then embraced a new entrepreneurial challenge in Finland, working as the business-oriented CSO for the microfluidic startup Finnadvance.
​
In both roles, I conducted market analyses to guide the development of MPS products, ensuring optimal market fit and strategic brand positioning. I also led collaborations with biotech companies, pharmaceutical firms, and academic laboratories. As a CSO and COO, I oversaw the standardization of cell and spheroid culture practices, enhancing reproducibility, cost-effectiveness, and scalability for increased throughput for proper market fit. I'm also co-author of 12 scientific publications.
Contact
Any question / inquiry? Feel free to reach out, and I'll get back to you promptly.
Toward higher complexity preclinical in vitro testing market
​​
The use of cell-based in vitro tests is essential for the development of therapies. These tests have significant potential to replace or reduce animal experiments, supported by FDA modernization acts 2.0 / 3.0 and new approach methodologies NAMs. This shift is expected to drive market growth and open up new business opportunities for in vitro assays, though it will also add to their complexity.
The recent rise of microphysiological systems (MPS) offers great promise in improving the predictability of in vitro testing. These innovative methods utilize complex platforms designed to replicate organ micro-environments using techniques such as 3D cell culture, mechanical stimuli, and microfluidics.
MPS are a game changer in the in vitro assay market, with adoption already widespread among most major pharmaceutical companies. There are currently over 40 commercial MPS providers, offering varying formats, capacities, and complexity. Understanding this complexity is crucial for identifying both opportunities and risks in this rapidly advancing field.
​
Organo-consulting is a specialized consulting service designed to help your business navigate and generate value in the fast-evolving preclinical in vitro testing market.